ArticleCureus2026
Cesarean Scar Pregnancy Diagnosed in the First Trimester: A Report of Two Cases and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy characterized by implantation of the gestational sac within a previous cesarean section scar. Its incidence has increased in parallel with rising global cesarean delivery rates. Early diagnosis is critical to prevent life-threatening complications such as uterine rupture and severe hemorrhage. We report two first-trimester CSP cases. The first involved a 30-year-old woman with three previous cesarean sections presenting with pelvic pain and hemoperitoneum. Emergency laparotomy with excision of the gestational tissue and uterine scar repair was performed. The second case concerned a 37-year-old woman diagnosed early by transvaginal ultrasound and successfully treated with a two-dose systemic methotrexate regimen, achieving complete biochemical and sonographic resolution. Transvaginal ultrasound is the cornerstone of CSP diagnosis. Management options include systemic or local methotrexate, hysteroscopic or laparoscopic resection, uterine artery embolization, or laparotomy in unstable patients. Treatment must be individualized according to hemodynamic status, gestational age, beta-human chorionic gonadotropin (β-hCG) level, myometrial thickness, and future fertility desire. CSP requires early recognition and tailored management. These cases illustrate the variability in clinical presentation and emphasize the importance of first-trimester ultrasound evaluation in women with previous cesarean deliveries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.